Ubicación del inventario

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Sujeto a disponibilidad

Documentation

Descargar MSDS

Descargar COA de muestra

Incluye: HPLC, MASS/LC-MS, RMN de 1H, FT-IR, potencia, informe de elucidación estructural (SER) y datos analíticos adicionales según el producto.

15307-86-5Aceclofenac EP Impurity A

● En Stock

Número de catálogo:	VL284007
N.º CAS:	15307-86-5
Fórmula mol.::	C14H11Cl2NO2
Peso mol.::	296.15 g/mol

Solicitar cotización

Añadir a la lista de RFQ

Información adicional sobre el CAS 15307-86-5

Fármaco de origen

Aceclofenac

Characterization Data (Included)

HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, and Structure Elucidation Report (SER).

Datos adicionales de caracterización

QNMR, D2O Exchange, 13C NMR, 13C APT, COSY NMR, NOESY NMR, 15N NMR, HSQC NMR, HMQC NMR, and HMBC NMR. These are available upon request and may be free or subject to additional charges.

Nombre IUPAC

2-(2-((2,6-dichlorophenyl)amino)phenyl)acetic acid

Pharmacopeial Synonyms

Diclofenac

Sinónimos

Benzeneacetic acid, 2-[(2,6-dichlorophenyl)amino]-; Diclofenac acid; [ 2-(2,6-Dichloroanilino)phenyl]acetic acid

SMILES

C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl

InChI

InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)

Condición de envío

Ambient Temperature

Descripción

Aceclofenac EP Impurity A, also referred to in pharmacopoeias as Diclofenac, is a meticulously characterized reference standard. It adheres to stringent regulatory guidelines, including those established by USP, EMA, JP, and BP. This product plays a vital role in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial manufacturing of Aceclofenac. Furthermore, it is accompanied by a comprehensive Structure Elucidation Report (SER), ensuring its accuracy and reliability across various analytical applications. Also known as Diclofenac Sodium, Dichlofenac, Diclofenac Acid, it is a non-steroidal anti-inflammatory drug (NSAID) supported for use in painful and inflammatory rheumatic and some non-rheumatic conditions. It suppresses acute and chronic inflammation, pain, and hyperthermia in various animal models.

Referencias

Todd, Peter A., and Eugene M. Sorkin. “Diclofenac Sodium.” Drugs, vol. 35, no. 3, Mar. 1988, pp. 244–85, https://doi.org/10.2165/00003495-198835030-00004. ?